These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24510011)

  • 1. Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models.
    Do J; Foster D; Renier C; Vogel H; Rosenblum S; Doyle TC; Tse V; Wapnir I
    Breast Cancer Res Treat; 2014 Feb; 144(1):93-101. PubMed ID: 24510011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models.
    Leten C; Struys T; Dresselaers T; Himmelreich U
    J Neurooncol; 2014 Sep; 119(2):297-306. PubMed ID: 24990826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of blood-brain barrier permeability assays: Revisiting old traumatic brain injury rat data for new insights and experimental design.
    Bolden CT; Olson SD; Cox CS
    Microvasc Res; 2023 Jan; 145():104453. PubMed ID: 36356686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Evans Blue Dye to Determine Blood-Brain Barrier Integrity in Rodents.
    Goldim MPS; Della Giustina A; Petronilho F
    Curr Protoc Immunol; 2019 Sep; 126(1):e83. PubMed ID: 31483106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying blood-brain-barrier leakage using a combination of evans blue and high molecular weight FITC-Dextran.
    Xu Y; He Q; Wang M; Wang X; Gong F; Bai L; Zhang J; Wang W
    J Neurosci Methods; 2019 Sep; 325():108349. PubMed ID: 31283939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and vascular integrity of breast cancer brain metastasis.
    Lu W; Bucana CD; Schroit AJ
    Int J Cancer; 2007 Mar; 120(5):1023-6. PubMed ID: 17187362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier integrity in a rat model of emergency preservation and resuscitation.
    Lahoud-Rahme MS; Stezoski J; Kochanek PM; Melick J; Tisherman SA; Drabek T
    Resuscitation; 2009 Apr; 80(4):484-8. PubMed ID: 19203824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.
    Klohs J; Steinbrink J; Bourayou R; Mueller S; Cordell R; Licha K; Schirner M; Dirnagl U; Lindauer U; Wunder A
    J Neurosci Methods; 2009 May; 180(1):126-32. PubMed ID: 19427539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.
    Kim LS; Huang S; Lu W; Lev DC; Price JE
    Clin Exp Metastasis; 2004; 21(2):107-18. PubMed ID: 15168728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
    Mustafa DAM; Pedrosa RMSM; Smid M; van der Weiden M; de Weerd V; Nigg AL; Berrevoets C; Zeneyedpour L; Priego N; Valiente M; Luider TM; Debets R; Martens JWM; Foekens JA; Sieuwerts AM; Kros JM
    Acta Neuropathol; 2018 Apr; 135(4):581-599. PubMed ID: 29350274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach.
    Percy DB; Ribot EJ; Chen Y; McFadden C; Simedrea C; Steeg PS; Chambers AF; Foster PJ
    Invest Radiol; 2011 Nov; 46(11):718-25. PubMed ID: 21788908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
    Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
    Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for determining blood-brain barrier integrity based on intracardiac perfusion of an Evans Blue-Hoechst cocktail.
    del Valle J; Camins A; Pallàs M; Vilaplana J; Pelegrí C
    J Neurosci Methods; 2008 Sep; 174(1):42-9. PubMed ID: 18647619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.
    Palmieri D; Lockman PR; Thomas FC; Hua E; Herring J; Hargrave E; Johnson M; Flores N; Qian Y; Vega-Valle E; Taskar KS; Rudraraju V; Mittapalli RK; Gaasch JA; Bohn KA; Thorsheim HR; Liewehr DJ; Davis S; Reilly JF; Walker R; Bronder JL; Feigenbaum L; Steinberg SM; Camphausen K; Meltzer PS; Richon VM; Smith QR; Steeg PS
    Clin Cancer Res; 2009 Oct; 15(19):6148-57. PubMed ID: 19789319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
    Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
    J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats.
    Belayev L; Busto R; Zhao W; Ginsberg MD
    Brain Res; 1996 Nov; 739(1-2):88-96. PubMed ID: 8955928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
    Kabraji S; Ni J; Lin NU; Xie S; Winer EP; Zhao JJ
    Clin Cancer Res; 2018 Apr; 24(8):1795-1804. PubMed ID: 29437794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
    Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
    J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.